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HIGHLIGHTS 23 
- Hydroxylation of DCF at the aromatic rings modulates its photo(geno)toxic potential 24 
- 5OH-DCF metabolite is phototoxic to cells, as demonstrated by the 3T3 NRU assay 25 
- DNA ssb photosentized by DCF and 5OH-DCF is observed on agarose gel 26 
electrophoresis 27 
- Comet assay reveals the photodamage induced by DCF and 5OH-DCF to cellular 28 
DNA  29 














Diclofenac (DCF) can cause adverse reactions such as gastrointestinal, renal and 44 
cardiovascular disorders; therefore, topical administration may be an attractive 45 
alternative to the management of local pain in order to avoid these side effects. 46 
However, previous studies have shown that DCF, in combination with sunlight, displays 47 
capability to induce photosensitivity disorders. In humans, DCF is biotransformed into 48 
hydroxylated metabolites at positions 4’ and 5 (4’OH-DCF and 5OH-DCF), and this 49 
chemical change produces non negligible alterations of the drug chromophore, resulting 50 
in a significant modification of its light-absorbing properties. In this context, 5OH-DCF 51 
exhibited higher photo(geno)toxic potential than the parent drug, as shown by several in 52 
vitro assays (3T3 NRU phototoxicity, DNA ssb gel electrophoresis and COMET), 53 
whereas 4’OH-DCF did not display significant photo(geno)toxicity. This could be 54 
associated, at least partially, with the more efficient UV-light absorption by 5OH-DCF 55 
metabolite. Interestingly, most of the cellular DNA damage photosensitized by DCF and 56 
5OH-DCF was repaired by the cells after several hours, although this effect was not 57 
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1. INTRODUCTION 66 
Diclofenac (2-(2,6-dichlorophenylamino)phenylacetic acid, DCF) is a widely prescribed 67 
nonsteroidal antiinflammatory drug (NSAID), which can be administered either 68 
topically or orally. It is therapeutically used in the treatment of several rheumatic 69 
diseases and as an analgesic. As DCF can cause severe adverse reactions such as 70 
gastrointestinal, renal and cardiovascular disorders, topical administration may be an 71 
attractive alternative to the management of local pain in order to avoid these side 72 
effects.1 However, previous studies have shown that DCF, in combination with sunlight, 73 
displays capability to induce photosensitivity reactions.2,3,4,5,6 74 
In this context, taking into account that metabolites can generate, upon irradiation, 75 
reactive intermediates capable of binding to key biomacromolecules such as DNA, 76 
identification of metabolites with phototoxic or adduct forming capability still remains a 77 
major challenge. Therefore, although biotransformation is normally associated with a 78 
decreased toxicity, metabolites may be more phototoxic and photoreactive than the 79 
parent drug.7,8,9 80 
Thus, in a previous work we have proven that demethylation of chlorpromazine (CPZ) 81 
as a consequence of Phase I biotransformation, does not result in a detoxification but 82 
leads to metabolites maintaining identical chromophore to the parent drug and 83 
exhibiting an even enhanced phototoxicity.10 84 
In humans, DCF is biotransformed into hydroxylated metabolites via oxidation of the 85 
aromatic rings by cytochrome P450 enzymes (CYPs).11,12 Major metabolic pathways are 86 
the hydroxylation in position 4’ and 5 (4’OH-DCF and 5OH-DCF, see Figure 1A), 87 
which unlike the case of CPZ demethylation are associated with a change in the 88 
chromophore. Moreover, as shown in Figure 1B both metabolites 4’OH-DCF and 5OH-89 
DCF display a bathochromic shift of the absorption band towards the UVA region, thus 90 
extending the active fraction of solar light able to produce photosensitivity disorders. 91 
With this background, the goal of the present work is to assess the photo(geno)toxic 92 
potential of DCF metabolites in order to investigate whether DCF biotransformation 93 
modulates the potential to photosensitize DNA damage. 94 
A) 95 
 96 
B)  97 
 98 
 99 
Figure 1. A) Chemical structures of diclofenac (DCF) and its metabolites 4’OH-DCF 100 
and 5OH-DCF. B) Ultraviolet spectra of DCF (red), 4’OH-DCF (blue) and 5OH-DCF 101 



















2. MATERIALS AND METHODS 103 
2.1 General chemicals and reagents  104 
All solvents were commercially available (HPLC grade) and were used without any 105 
further purification. Diclofenac sodium salt (DCF), 4’-hydroxydiclofenac (4’OH-DCF), 106 
5-hydroxydiclofenac (5OH-DCF) chlorpromazine (CPZ), sodium dodecyl sulphate 107 
(SDS), neutral red solution and DNA repair enzymes E coli formamidopyrimidine DNA 108 
glycosylase (Fpg) and E coli endonuclease III (Endo III) were provided by Sigma 109 
Aldrich (Madrid, Spain). For the preliminary experiments, 5-hydroxydiclofenac (5OH-110 
DCF) was synthesized by standard procedures.13 Supercoiled plasmid pBR322, DNA 111 
repair enzyme T4 endonuclease V (EndoV) and SYBR Safe DNA gel stain were 112 
purchased from Roche Diagnostics (Barcelona, Spain), Ecogen (Barcelona, Spain) and 113 
Invitrogen (Madrid, Spain), respectively. For cell culture experiments, fetal bovine 114 
serum (FBS), Dulbecco’s Modified Eagle Medium (DMEM) and penicillin-115 
streptomycin were supplied by Invitrogen (Madrid, Spain) and trypsine-EDTA (0.25%-116 
0.02%) and glutamine (100 mM) solutions were provided by Cultek (Madrid, Spain). 117 
Phosphate buffered saline solution (PBS, pH 7.4, 0.01 M) was prepared by dissolving 118 
Sigma tablets in the appropriate volume of ultrapure deionized water. Reagent kit for 119 
single cell electrophoresis assay was supplied by Trevigen (Barcelona, Spain).  120 
2.3 UV Absorption spectra  121 
Ultraviolet absorption spectra were recorded on a Shimadzu UV-1800 UV/VIS 122 
spectrophotometer. Measurements were performed in PBS (4 × 10-5 M) at room 123 
temperature using 1 cm quartz cells with 3.5 mL capacity. 124 
 125 
 126 
2.4 Irradiation equipment  127 
The UV light source used in all in vitro photosensitization assays was a photoreactor 128 
model LZC-4 (Luzchem, Canada) equipped with 14 lamps for top and side irradiation 129 
(λmax = 350 nm, Gaussian distribution). All irradiations were carried out through the lid 130 
of the plates, and in order to avoid overheating ventilation was used and the plates were 131 
placed on ice during the irradiation step.  132 
2.5 DNA damage induced by photosensitization 133 
Mixtures containing 200 ng of supercoiled circular plasmid pBR322 and DCF (100 μM) 134 
or its metabolites (100 μM) were irradiated as described above. Digestion with an 135 
excess of the repair enzymes (Fpg, Endo III or Endo V) was performed immediately 136 
after UVA irradiation in order to reveal the nature of DNA damages. Upon 137 
irradiation/digestion, loading buffer (0.25 % bromophenol blue, 0.25 % xylene cyanol, 138 
30 % glycerol in water) was added to each sample. All the samples were loaded on a 0.8 139 
% agarose gel containing SYBR® Safe as dye of nucleic acid. Electrophoresis was 140 
carried out in Tris-acetate-EDTA (TAE) buffer (0.004 M Tris-acetate, 1 mM EDTA) at 141 
100 V for 1 h. Next, the DNA bands were detected under UV light irradiation and 142 
visualized using a Gel Logic 200 Imaging System (Kodak). Finally, the relative 143 
abundance of supercoiled DNA (Form I) and nicked relaxed DNA (Form II) was 144 
quantified by densitometry with the image analyzer Quantity One (Biorad). 145 
2.6 Assessment of cellular photo(geno)toxicity 146 
2.6.1 In Vitro 3T3 neutral red uptake (NRU) phototoxicity test 147 
BALB/c 3T3 fibroblast cell line was grown in DMEM supplemented with 10% FBS, 4 148 
mM glutamine and 1% penicillin/streptomycin and routinely maintained in 75 cm2 149 
plastic flasks in a humidified incubator at 37 °C under 5 % CO2 atmosphere. The 3T3 150 
NRU phototoxicity test was performed according to the OECD guideline 43214 with 151 
minor modifications. For each compound two 96-wells plates were seeded at a density 152 
of 2.5 × 104 cells/well. Serial dilutions of the test compounds ranging from 4 mM to 153 
0.05 mM were added to each plate. After a period of 1h incubation, one plate was 154 
irradiated with a dose of UVA equivalent to 5 J/cm2 (UVA light), whereas the other 155 
plate was kept in a dark box (dark). The viability of UVA-treated control cells in the 156 
absence of test compounds was >90% of those kept in the dark indicating the suitability 157 
of the UV dose. At the end of the UVA exposure plates were replaced with DMEM 158 
medium and then incubated overnight. Next day neutral red solution (50 μg/mL) was 159 
added into each well and incubated for 2 h. After that, neutral red medium was 160 
discarded, cells were washed with PBS and neutral red extraction was achieved with 161 
100 μL of the desorption solution (water 49% (v/v), ethanol 50% (v/v) and acetic acid 162 
1% (v/v). The absorbance was recorded at 550 nm on a Multiskan Ex microplate reader. 163 
For each compound dose-response curves were developed, which allowed the 164 
determination of IC50 values (concentration of compound causing a 50% reduction of 165 
the neutral red uptake) in the absence and in the presence of radiation. Finally, the 166 
Photo-Irritation-Factor (PIF) was calculated with the following equation: 𝑃𝐼𝐹 =167 
 
 IC50 DARK 
IC50 UVA LIGHT
. According to the OECD Guideline14 a test compound is labeled as 168 
“phototoxic” if PIF is >5, “probably phototoxic” if PIF >2 and <5, and “non-169 




2.6.2 Nuclear DNA damage by COMET assay 174 
The single cell gel electrophoresis assay, also known as comet assay, was performed as 175 
previously described10 with slight modifications. Human fibroblasts (FSK cell line) 176 
were trypsinized, resuspended in cold PBS and placed on ice for 2h. Cells (100000 177 
cells/well in two 12-well plates) were seeded and treated with 100 μM of DCF or its 178 
metabolites. CPZ (10 μM) was used as a positive control. After 1h incubation, one plate 179 
was placed in the photoreactor in order to irradiate the cells for 5 min on ice, whereas 180 
the other one was kept in a dark box. Next, 100 μL of each cell suspension were mixed 181 
carefully with 100 μL of 1% low melting point agarose solution and drops were loaded 182 
onto Trevigen® treated slides and placed on ice-cold tray to allow its jellification. Then 183 
the slides were immersed in coupling jars containing cold lysis buffer (2.5M NaCl, 0.1 184 
M Na2EDTA, 0.01 M Tris, 1% Triton X-100 in distilled water and pH 10) and 185 
overnight incubated at 4 °C. In DNA-recovery assays, after drop jellification, the slides 186 
were incubated in DMEM medium at 37 ºC for different time periods (3h, 6h or 18h) 187 
and then subjected to cell lysis. Next day all slides were placed in a Trevigen® Comet 188 
assay electrophoresis tank (10 slides per run), covered with 850 mL of cold alkaline 189 
electrophoresis buffer (0.2 M NaOH, 1mM EDTA in distilled water and pH ≥13) and let 190 
during 40 min for DNA unwinding at 4 °C. Afterwards, the electrophoresis was run at 191 
21 V (≈300 mA) for 30 min at 4 °C. When the electrophoresis finished, the slides were 192 
neutralized twice in PBS for 5 min and washed once with miliQ water for 5min; DNA 193 
was fixed by slide incubation in 70% ethanol for 5 min followed by other 5 min in 194 
100% ethanol, and then air-dried. Finally, comet nucleoids and tails were stained by 195 
incubating the slides in a SYBR Gold® (1:10000 TE buffer) bath for 30 min, air dried, 196 
and kept in darkness until further visualization. For nucleoids and tails DNA 197 
visualization a Leica DMI 4000B fluorescence microscope was used and ≥5 pictures 198 
were taken for each sample. Finally, DNA % in tail as a measure of DNA damage was 199 
determined for each condition with the analysis of at least 100 DNA comets with the 200 
open source analysis software Open Comet 1.315  201 
3. RESULTS AND DISCUSSION 202 
3.1 Phototoxicity  203 
In vitro 3T3 NRU phototoxicity assay was performed in order to assess the cell viability 204 
upon exposure to DCF and its metabolites in combination with UVA irradiation (5 205 
J/cm2). Accordingly, cytotoxicity profiles of BALB/c 3T3 fibroblasts treated with DCF, 206 
4’OH-DCF and 5OH-DCF were measured, using neutral red as vital dye, both in dark 207 
and in the presence of UVA light. Thus, the IC50 values were determined from dose-208 
response curves for cell viability of cells treated under the conditions described above in 209 
the materials and methods section (dose-response curves are provided in Supplementary 210 
material, Figure S1). 211 
The aim of NRU test is to calculate the PIF that corresponds to the ratio of the IC50 212 
under dark or light conditions for each compound. As shown in Table 1, 5OH-DCF 213 
metabolite resulted to be potentially phototoxic with a PIF value ca. 12, 4 fold more 214 
phototoxic than the parent drug. Both DCF and 4’OH-DCF displayed a PIF of 3 and 2, 215 
respectively, which can be considered as probable phototoxicity. Table 1 collects the 216 
IC50 under dark and UVA light conditions as well as the PIF of all compounds tested.  217 
It is known that the photosensitizing properties of DCF are associated with the main 218 
photoproduct, which corresponds to a chlorocarbazole derivative, as revealed in 219 
photohemolysis and lipid photoperoxidation assays.2 Thus, the key process is the 220 
photodechlorination, triggered by homolytic carbon-chlorine bond cleavage with 221 
generation of a highly reactive aryl radical and choride anion.16 Assuming that this 222 
reaction occurs in the parent drug as well as in the metabolites under study, the higher 223 
phototoxicity of 5OH-DCF could be associated, at least partially, with its more efficient 224 
UV-light absorption. 225 
Table 1. Phototoxicity of DCF and its metabolites in the 3T3 NRU Assay 226 
 





CPZ 84 ± 18 4 ± 1 21 
DCF 688 ± 63 254 ± 58 3 
4’OH-DCF 766 ± 85 375 ± 55 2 
5OH-DCF 813 ± 106 68 ± 27 12 
SDS 202 ± 25 244 ± 48 1 
227 
Data are the mean± SD of five independent experiments performed in triplicate. CPZ 228 
and SDS were used as positive and negative controls of phototoxicity respectively.  229 
1According to the OECD 432 Guide (2004), PIF<2 predicts “no phototoxicity”, 230 
2<PIF<5 predicts “probable phototoxicity” and PIF>5 predicts “phototoxicity”.  231 
 232 
3.2 Photogenotoxicity of DCF and its metabolites 233 
Irradiations of DCF, 4’OH-DCF and 5OH-DCF in the presence of supercoiled circular 234 
DNA (pBR322) were performed using a multilamp photoreactor (max = 355 nm) in 235 
order to detect DNA damage. Quantification by densitometry of the conversion of 236 
native supercoiled form I into circular form II (Figure 2A) shown in agarose gel (Figure 237 
2B) evidenced single strand break (ssb) formation. It is interesting to note that 5OH-238 
DCF exhibited higher photogenotoxic potential than the parent drug whereas 4’OH-239 
DCF did not display significant photogenotoxicity (Figure 2). 240 
Moreover, in order to reveal the nature of damages induced on the DNA bases, different 241 
DNA–repair enzymes were used: i) T4 endonuclease V (Endo V) for cyclobutane 242 
thymine dimers (CPDs), ii) endonuclease III (Endo III) for degradation products of 243 
pyrimidine bases and iii) formamidopyrimidine DNA glycosylase (FPG) for oxidized 244 
purines. Thus, ssb formation was enhanced for 5OH-DCF metabolite (data reported in 245 
Supplementary material, Figure S2) in all cases.  246 
 247 
Figure 2. A) Induction of single strand brakes (ssb) in supercoiled circular pBR322 248 
plasmid (200 ng/µL) alone (negative control, NC) or treated with DCF and its 249 
metabolites at 100 µM upon 30 minutes UVA irradiation (□) or not (■) using a 250 
multilamp photoreactor λmax = 350 nm. DNA Form II was quantified by densitometry of 251 
agarose gel electrophoresis. Data represent the mean ± SD of four independent 252 
experiments and asterisks indicate significant differences relative to the formation of 253 
DNA Form II in Dark conditions by the T-Student test (**p<0.01). B) Agarose gel 254 
electrophoresis of plasmid pBR322 alone (NC) or in the presence of 5OH-DCF, in the 255 
dark (-) or upon 5 minutes UVA irradiation (+). Ketoprofen was used as positive control 256 
(PC).  257 
Assessment of cellular photogenotoxicity was performed by Comet assay under alkaline 258 
conditions to reveal the combined nuclear DNA damage resulting from single-strand 259 
breaks, double-strand breaks and alkali-labile sites. For this purpose, human fibroblasts 260 
(FSK) were embedded in agarose on a slide and incubated for 1 h with DCF and its 261 
hydroxylated metabolites. Next, alkaline electrophoresis was carried out after 5 min of 262 
UVA exposure (2 J/cm2) and subsequent lysis. In the course of electrophoresis, the 263 
damaged and fragmented DNA migrates away from the nucleus and upon staining with 264 
SYBR Gold the fluorescence of the nuclei was observed. Percentage of DNA damage 265 
was calculated by means of OpenComet software. 266 
 267 
 268 
Figure 3. Alkaline comet assay and DNA repair capability of FSK cells treated with 269 
DCF and its metabolites. A) Percentage of DNA damage calculated by OpenComet 270 
software of untreated FSK cells (Negative control, NC) or treated with DCF and its 271 
metabolites (100 μM). Cells were left unexposed (Dark, ■), irradiated for 5 minutes 272 
(UVA Light, □) or irradiated for 5 minutes followed by 6 h of cell recovery (UVA Light 273 
+ Time recovery 6h, ■), respectively. Data are the mean ± SD of three independent 274 
experiments. Asterisks indicate significant differences relative to the untreated FSK 275 
cells in dark conditions by the T-Student test (*p<0.05; **p<0.01; ***p<0.001). B) 276 
Fluorescence microscopy images of DCF and 5OH-DCF Comet assay experiments. 277 
As shown in Figure 3, 5OH-DCF showed again higher photogenotoxicity than the 278 
parent drug DCF and 4’OH-DCF metabolite (see Supplementary material, Figure S3). 279 
Moreover, another set of experiments were performed in order to investigate the ability 280 
of FSK cells to repair nuclear DNA damage generated by DCF and metabolites in 281 
combination with UVA light. For this purpose, FSK cells treated (with drug and 282 
metabolites) and irradiated were incubated for different time periods (3h, 6h and 18h) 283 
and the remaining DNA damage was calculated as described above. As a general trend 284 
DNA damage decreased with the time of recovery. Interestingly, for DCF it was shown 285 
that most DNA damage was repaired within 3h after irradiation whereas for 5OH-DCF 286 
a significant residual DNA damage (around 25%) was still present even after 18 h of 287 
cell recovery (Figure 3 and Supplementary material, Figure S4).  288 
4. CONCLUSION 289 
Hydroxylation of the aromatic rings at positions 4’ and 5 occurs during phase I 290 
biotransformation of DCF. This chemical change produces non negligible alterations of 291 
the drug chromophore and results in a significant modification of its light-absorbing 292 
properties. Accordingly, the phototoxic and photogenotoxic potential of DCF, 4’OH-293 
DCF and 5OH-DCF are expectedly different, as indicated by 3T3 NRU phototoxicity 294 
assay, the DNA single strand break gel electrophoresis assay and the COMET assay. 295 
The most remarkable result is the enhanced photo(geno)toxicity of 5OH-DCF, which 296 
was consistently observed in all experiments. Interestingly, most of the cellular DNA 297 
damage photosensitized by DCF and 5OH-DCF was repaired by the cells after several 298 
hours, although this effect was not complete in the case of 5OH-DCF. 299 
 300 
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